NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-9.47%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.41B
AUM Growth
+$2.41B
Cap. Flow
+$138M
Cap. Flow %
5.72%
Top 10 Hldgs %
73.82%
Holding
49
New
5
Increased
3
Reduced
1
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$851M 35.27% 10,275,113
CBIO
2
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$144M 5.97% 8,584,128
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$6.85B
$143M 5.91% +4,912,306 New +$143M
MRSN icon
4
Mersana Therapeutics
MRSN
$36.5M
$134M 5.54% 8,144,267
DERM
5
DELISTED
Dermira, Inc.
DERM
$97.5M 4.04% 3,506,649
ARDX icon
6
Ardelyx
ARDX
$1.53B
$93M 3.85% 14,083,582
SENS icon
7
Senseonics Holdings
SENS
$374M
$82.2M 3.4% 30,888,266 -2,537,009 -8% -$6.75M
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$81.1M 3.36% 6,460,851
ADAP
9
Adaptimmune Therapeutics
ADAP
$15.6M
$80.3M 3.33% 12,025,999
CRSP icon
10
CRISPR Therapeutics
CRSP
$4.71B
$75.6M 3.13% 3,220,728
AKAO
11
DELISTED
Achaogen, Inc.
AKAO
$56M 2.32% 5,215,128
AVEO
12
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$45.7M 1.89% 16,362,694
IMMU
13
DELISTED
Immunomedics Inc
IMMU
$44.8M 1.86% 2,772,643
OBSV
14
DELISTED
ObsEva SA Ordinary Shares
OBSV
$44.8M 1.85% 4,586,563 +1,250,000 +37% +$12.2M
CMTA
15
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$40.6M 1.68% 2,141,697
SYBX icon
16
Synlogic
SYBX
$17M
$37M 1.53% 3,819,410
CASC
17
DELISTED
Cascadian Therapeutics, Inc.
CASC
$33.5M 1.39% 9,064,575
KA
18
DELISTED
Kineta, Inc. Common Stock
KA
$32.4M 1.34% 5,556,778 +2,000,000 +56% +$11.7M
SBBP
19
DELISTED
Strongbridge Biopharma plc.
SBBP
$30M 1.24% 4,141,308
RARX
20
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$29.7M 1.23% 3,493,636
TNTR
21
DELISTED
Tintri, Inc. Common Stock
TNTR
$26.8M 1.11% 5,253,358
XFOR icon
22
X4 Pharmaceuticals
XFOR
$84.3M
$25.5M 1.06% +2,000,000 New +$25.5M
LXRX icon
23
Lexicon Pharmaceuticals
LXRX
$400M
$23.5M 0.98% 2,382,286
AUPH icon
24
Aurinia Pharmaceuticals
AUPH
$1.58B
$21.8M 0.9% 4,808,483
VRNA
25
Verona Pharma
VRNA
$9.16B
$14.5M 0.6% 1,219,674